Raymond James Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History

Raymond James Financial’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$373K	Sell	19,055 -65,399	-77%	-$1.6M	﹤0.01%	4540
2025 Q4	$2.26M	Sell	84,454 -33,733	-29%	-$869K	﹤0.01%	3176
2025 Q3	$3.15M	Buy	118,187 +1,068	+0.9%	+$27.6K	﹤0.01%	2815
2025 Q2	$2.69M	Buy	117,119 +87,447	+295%	+$2.17M	﹤0.01%	2837
2025 Q1	$860K	Sell	29,672 -63,232	-68%	-$2.02M	﹤0.01%	3597
2024 Q4	$3.45M	Buy	+92,904	New	+$4.25M	﹤0.01%	2577

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Raymond James Financial's AMPH Position: Q1 2026 in Review

Raymond James Financial reduced its Amphastar Pharmaceuticals (AMPH) stake by 77% in Q1 2026, selling an estimated $1.6M and leaving 19,055 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #4540.

Raymond James Financial first reported a position in AMPH in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.45M in Q4 2024. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

Raymond James Financial held 19,055 shares of Amphastar Pharmaceuticals worth $373K as of Q1 2026.
Raymond James Financial sold 65,399 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $1.6M.
Amphastar Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #4540 holding.
Raymond James Financial first reported a position in Amphastar Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
Raymond James Financial's Amphastar Pharmaceuticals position peaked at $3.45M in Q4 2024.
215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.